Skip to main content

Luteal Phase and Embryonic Development in GnRH-Agonist/hMG-Cycles for In Vitro Fertilization

  • Chapter
Advances in Assisted Reproductive Technologies

Abstract

The combined GnRH-agonist hMG-stimulation has now become a worthwhile tool as a second line therapy in vitro fertilization (IVF) under special conditions such as premature LH-surge and hyperandrogenemia. Several authors even propose this treatment as a first line therapy with an increased overall pregnancy rate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Birnbaugier, L., Shahabi, N., Rivier, J., and Vale, W., 1985, Evidence for a physiological role of gonadotropin-releasing hormone (GnRH) or GnRH-like material in the ovary, Endocrinology, 116:1367.

    Article  Google Scholar 

  • Dodson, W.C., Myers, T., Morton, P.C., and Conn, P.M., 1988, Leuprolide acetate: serum and follicular fluid concentrations and effect on human fertilization, embryo growth and granulosa-lutein cell progesterone accumulation in vitro, Fertil. Steril., 50:612.

    PubMed  CAS  Google Scholar 

  • Hsueh, A.J.W., and Jones, P.B.C., 1981, Extrapituitary actions of gonadotropin-releasing hormone, Endocrine Reviews, 2:437.

    Article  PubMed  CAS  Google Scholar 

  • Parinaud, J., Beaur, A., Bourreau, E., Vieitez, G., and Pontonnier, G., 1988, Effect of a luteinizing hormone-releasing hormone agonist (Buserelin) on steroidogenesis of cultured human preovulatory granulosa cells, Fertil. Steril 50:597.

    PubMed  CAS  Google Scholar 

  • Sandow, J., 1983, Clinical applications of LHRH and its analogues, Clin. Endocr., 18:571.

    Article  PubMed  CAS  Google Scholar 

  • Schmutzler, R.K., Reichert, C., Diedrich, K., Wildt, L., Diedrich, Ch., Al-Hasani, S., van der Ven, H., and Krebs, D., 1988, Combined GnRH-agonist/gonadotropin stimulation for in vitro-fertilization, Hum. Reprod., 3:29.

    PubMed  Google Scholar 

  • Testart, J., Forman, R., Belaisch-Allart, J., Volante, M., Hazout, A., Strubb, N., and Frydman, R., 1989, Embryo quality and uterine receptivity in in vitro fertilization cycles with or without agonists of gonadotropin-releasing hormone, Human Reprod., 4:198.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Shlomo Mashiach M.D. Zion Ben-Rafael M.D. Neri Laufer M.D. Joseph G. Schenker M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Plenum Press, New York

About this chapter

Cite this chapter

Schmutzler, R.K. et al. (1990). Luteal Phase and Embryonic Development in GnRH-Agonist/hMG-Cycles for In Vitro Fertilization. In: Mashiach, S., Ben-Rafael, Z., Laufer, N., Schenker, J.G. (eds) Advances in Assisted Reproductive Technologies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0645-0_39

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0645-0_39

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-7907-5

  • Online ISBN: 978-1-4613-0645-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics